U.S. Point‑of‑Care Diagnostics Market Projected to Reach $604 B by 2035

The U.S. point‑of‑care (PoC) diagnostics market was valued at $9.45 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of about 6.9% through 2034, driven by rising disease prevalence, higher healthcare spending, and advances in digital health, AI and precision medicine.

A broader global forecast predicts the PoC diagnostics market will expand from $328.7 billion in 2025 to $604.3 billion by 2035, reflecting a CAGR of roughly 7.3% over the 2025‑2035 period. Growth is fueled by rapid‑test demand, adoption of multiplex and molecular platforms, integration of IoT and AI for connected diagnostics, and the shift toward decentralized and home‑based care.

Key players highlighted in the reports include Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann‑La Roche, Quest Diagnostics, Siemens Healthcare and other major manufacturers that are investing in next‑generation PoC technologies.